What is physIQ?
PhysIQ stands at the forefront of digital medicine, leveraging continuous wearable biosensor data and sophisticated analytics to unlock profound health insights. The company's enterprise-ready cloud platform is designed to seamlessly collect and process data from any wearable biosensor, supported by a comprehensive portfolio of FDA-cleared analytics. physIQ has distinguished itself through rigorous clinical studies in digital medicine, pioneering the development, validation, and regulatory approval of artificial intelligence-based analytics. Its innovative solutions are applied across clinical trial support and broader healthcare sectors, aiming to revolutionize how physiological data is utilized by health systems, payers, and pharmaceutical entities.
How much funding has physIQ raised?
physIQ has raised a total of $19.9M across 5 funding rounds:
Series A
$4.6M
Private Equity
$3.6M
Series B
$8M
Unspecified
$3.3M
Debt
$350K
Series A (2014): $4.6M with participation from LionBird Ltd.
Private Equity (2016): $3.6M, investors not publicly disclosed
Series B (2017): $8M supported by Quark Venture Inc., GF Securities, LionBird, and 4490 Ventures
Unspecified (2019): $3.3M, investors not publicly disclosed
Debt (2020): $350K backed by PPP
Key Investors in physIQ
Quark Venture Inc.
Quark Venture Inc. is a venture capital firm specializing in equity financing for innovative biotechnology companies. They focus on supporting companies with breakthrough technology platforms to enhance their capabilities and achieve high growth through diversified healthcare products and services.
LionBird
LionBird is a venture capital firm that invests in innovative health-tech startups aiming to transform healthcare through technology. They provide pre-scale capital and strategic support to promising companies dedicated to improving healthcare solutions.
4490 Ventures
4490 Ventures, founded by Katie Lord, focuses on branding, marketing, and website creation for startups, aiming to help them secure venture capital funding. They provide agency-quality work with a transparent business model to bring innovative ideas to life.
What's next for physIQ?
The recent strategic investment signals a new phase of growth and market expansion for physIQ. With a strong foundation in validated AI-driven analytics and regulatory approvals, the company is well-positioned to scale its operations and deepen its impact within the healthcare and pharmaceutical industries. This capital will likely fuel further research and development, enhance its platform capabilities, and broaden its market reach, solidifying its leadership in the digital medicine space. The company's trajectory suggests a focus on strategic partnerships and the continued integration of its technology into mainstream healthcare delivery and clinical research.
See full physIQ company page
